MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with C

Canagliflozin

Canagliflozin 100mg tablets

Compatible

Stability notes for Canagliflozin 100mg tablets

No stability data in MCAs available but no theoretical concerns with product

Provenance

This recommendation is based on the products Invokana 100 mg film-coated tablets (A. Menarini Farmaceutica Internazionale SRL)

Suppliers

Invokana 100mg tablets (A. Menarini Farmaceutica Internazionale SRL)
Invokana 100mg tablets (Pharmaram Ltd)

Canagliflozin 300mg tablets

Compatible

Stability notes for Canagliflozin 300mg tablets

No stability data in MCAs available but no theoretical concerns with product

Provenance

This recommendation is based on the products Invokana 300 mg film-coated tablets (A. Menarini Farmaceutica Internazionale SRL)

Supplier

Invokana 300mg tablets (A. Menarini Farmaceutica Internazionale SRL)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.